A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called APS-1.

In a proof-of-concept study, researchers at the NIH have developed an AI tool that uses routine clinical data to predict whether someone’s cancer will respond to immune checkpoint inhibitors,

The National Cancer Institute will award $23 million to four academic institutions to establish centers of excellence that will conduct research on the role of telehealth in delivering cancer-related health care.